Home
>
National Drug Code (NDC)
>
BACTROBAN
BACTROBAN - 0029-1525-44 - (mupirocin)
Drug Information of BACTROBAN
| Product NDC: | 0029-1525 |
| Proprietary Name: | BACTROBAN |
| Non Proprietary Name: | mupirocin |
| Active Ingredient(s): | 20 mg/g & nbsp; mupirocin |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BACTROBAN
| Product NDC: | 0029-1525 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050591 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000407 |
Package Information of BACTROBAN
| Package NDC: | 0029-1525-44 |
| Package Description: | 22 g in 1 TUBE (0029-1525-44) |
NDC Information of BACTROBAN
| NDC Code | 0029-1525-44 |
| Proprietary Name | BACTROBAN |
| Package Description | 22 g in 1 TUBE (0029-1525-44) |
| Product NDC | 0029-1525 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mupirocin |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20000407 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | MUPIROCIN |
| Strength Number | 20 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | RNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA] |
